Actively Recruiting
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Led by Seung-Jung Park · Updated on 2026-01-02
50000
Participants Needed
1
Research Sites
1447 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
CONDITIONS
Official Title
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Coronary disease suitable for percutaneous coronary intervention (PCI)
- No clinical or lesion limitations
You will not qualify if you...
- Patients with a mixture of several drug-eluting stents
- Terminal illness with life expectancy less than 1 year
- Patients with cardiogenic shock
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here